Merus N.V. (MRUS)
NASDAQ: MRUS · Real-Time Price · USD
56.01
-1.57 (-2.73%)
Jun 5, 2025, 4:00 PM - Market closed
Merus Market Cap
Merus has a market cap or net worth of $3.88 billion as of June 6, 2025. Its market cap has increased by 51.40% in one year.
Market Cap
3.88B
Enterprise Value
3.25B
1-Year Change
51.40%
Ranking
Category
Stock Price
$56.01
Market Cap Chart
Since May 19, 2016, Merus's market cap has increased from $143.00M to $3.88B, an increase of 2,610.95%. That is a compound annual growth rate of 43.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2025 | 3.88B | 34.66% |
| Dec 31, 2024 | 2.88B | 81.33% |
| Dec 29, 2023 | 1.59B | 121.65% |
| Dec 30, 2022 | 716.30M | -41.96% |
| Dec 31, 2021 | 1.23B | 142.03% |
| Dec 31, 2020 | 509.90M | 55.03% |
| Dec 31, 2019 | 328.90M | 20.92% |
| Dec 31, 2018 | 272.00M | -12.85% |
| Dec 29, 2017 | 312.10M | 3.83% |
| Dec 30, 2016 | 300.60M | 110.21% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 687.52B |
| Johnson & Johnson | 368.66B |
| AbbVie | 330.92B |
| Novo Nordisk | 324.15B |
| UnitedHealth Group | 272.49B |
| Abbott Laboratories | 231.33B |
| Novartis AG | 229.87B |
| AstraZeneca | 226.47B |